We also observed that USP5 or EphA2 overexpression recovers radioresistance of NPC cells and their xenografted tumors treated with MBZ, indicating that MBZ sensitizes NPC cells to ionizing radiation by targeting USP5/EphA2 axis. The gene discussed is EPHA2; the disease is nasopharyngeal carcinoma.